You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 8, August 27, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  This Week in JAMA
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

This Week in JAMA

JAMA. 2008;300(8):875.

Nut, Corn, and Popcorn and Diverticular Disease

In an analysis of data from the Health Professionals Follow-up Study, Strate and colleagues assessed whether nut, corn, and popcorn consumption is associated with diverticulitis and diverticular bleeding in patients without known diverticular disease. The authors found no evidence that consumption of nuts, corn, or popcorn increases the risk of diverticulosis or diverticular complications during 18 years of follow-up in individuals without known diverticular disease.

(SEE ARTICLE)


Lead, Mercury, and Arsenic in Ayurvedic Medicines

Ayurveda is a traditional medical system that originated in India and is used by persons worldwide. High levels of lead, mercury, and arsenic have been found in ayurvedic medicines manufactured in South Asia and sold in retail stores, but the prevalence of metals in ayurvedic medicines sold via the Internet and in ayurvedic medicines manufactured in the United States is not known. In an analysis of a random sample of ayurvedic medicines available via the Internet, Saper and colleagues found that one-fifth of both US-manufactured and Indian-manufactured ayurvedic medicines contained lead, mercury, and arsenic at levels that exceeded one or more standards for acceptable daily metal intake.

(SEE ARTICLE)


Allopurinol and Adolescent Hypertension

Hyperuricemia is common in patients with new-onset essential hypertension, and evidence from animal models suggests that elevated uric acid levels may be in the causal pathway. In a randomized, placebo-controlled, crossover trial involving 30 hyperuremic adolescents with newly diagnosed hypertension, Feig and colleagues assessed whether lowering uric acid levels with allopurinol (200 mg twice daily for 4 weeks) would be associated with reductions in blood pressure. The authors report that compared with placebo, allopurinol was associated with significant reductions in casual and 24-hour ambulatory blood pressure.

(SEE ARTICLE)


CLINICIAN'S CORNER
Glucose Control in Critically Ill Adults

Many professional societies endorse tight glucose control in all critically ill adults. This recommendation is based largely on results from 1 clinical trial, which demonstrated that tight glucose control was associated with decreased mortality in a surgical intensive care unit. Subsequent studies have been inconclusive, and there is now controversy as to whether tight glucose control is warranted for all critically ill adults. Wiener and colleagues (SEE ARTICLE) pooled and analyzed data from 29 clinical trials in which adult patients in intensive care units were randomly assigned to tight vs usual glucose control. The authors report that tight glucose control was not associated with a significant reduction in hospital mortality but was associated with an increased risk of hypoglycemia. In an editorial, Finfer and Delaney (SEE ARTICLE) discuss the complexities of glucose control in critically ill patients.


Opt-Out Testing for HIV in the United States

The Centers for Disease Control and Prevention (CDC) has recommended HIV testing for all persons aged 13 to 64 years, a policy that requires persons who do not wish to know their HIV status to actively "opt-out" of testing. Bartlett and colleagues review the rationale for the CDC recommendation and discuss progress and challenges to implementation.

(SEE ARTICLE)


A Piece of My Mind

"[W]hy would I not stop all these heroic and futile treatments and just let Pamela die in peace and with dignity?" From "Seventy-two Hours."

(SEE ARTICLE)


Medical News & Perspectives

An alliance of influential nonprofit organizations and federal and state agencies is attempting to alleviate the ongoing nursing shortage by improving the capacity of US nursing schools to increase enrollment.

(SEE ARTICLE)


Commentaries

Enhancing the US Food and Drug Administration guidance on pharmacovigilance

(SEE ARTICLE)

Single-patient rooms for patient-centered care

(SEE ARTICLE)

Food safety for the 21st century

(SEE ARTICLE)


JAMA Classics

Yellow fever

(SEE ARTICLE)


Author in the Room Teleconference

Join H. George Nurnberg, MD, September 17 from 2 to 3 PM eastern time to discuss sildenafil for women with antidepressant-associated sexual dysfunction. To register, go to http://www.ihi.org/AuthorintheRoom.


Readers Respond

How would you manage a 39-year-old man with HIV-associated lipodystrophy? Go to www.jama.com, read the case, and submit your response, which may be selected for online publication. Submission deadline is August 27.


JAMA Patient Page

For your patients: Information about yellow fever.

(SEE ARTICLE)



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.